OClawVPS.com
Ahren Innovation Capital
Edit

Ahren Innovation Capital

https://www.ahreninnovationcapital.com/
Last activity: 12.01.2026
Active
Invests in categories: QuantumHealthTechArtificial IntelligenceSoftwareLearnAIPlatformTechnologyHardwareMachineLearning
Ahren is a deep tech and deep science investment firm set up by Alice Newcombe-Ellis alongside co-Founding Science Partners. Together, these Founders created companies and/or technologies that are today valued in excess of $100BN combined. The firm was established from first principles with a mission to be disruptive as an investment institution, with a new model – genuine partnership between the creators of deep technology and deep science, and commercially active, long-term capital, to harness tremendous global talent and build and exponentially accelerate the next generation of great enterprises. Ahren’s Portfolio companies include AI21 Labs, Graphcore, Zapata Computing, ZOE, Phaidra, Heirloom Carbon, and Bicycle Therapeutics among others. Ahren has >$800M AUM and has team members in Cambridge (UK), London, and Boston.
Followers
1.38K
News
32
Portfolio
27
Mentions
28
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2017
Investment Type: Venture Capital
Investment Stage: Seed; Series A; Series B

Portfolio 27

DateNameWebsiteTotal RaisedLocation
13.01.2026OutSeeoutsee.co.uk$5.82MEngland
10.12.2025Nu Quantumnu-quantum.com$74.85MUnited Kin...
12.09.2023Zapata AIzapata.ai-United Sta...
31.05.2023biomodalbiomodal.com-United Kin...
22.01.2023Pictura Bi...pictura.bio--
20.10.2022AmbiRoboti...ambirobotics.com$101.1MUnited Sta...
15.08.2022Constructi...constructive.bio$73MUnited Kin...
12.07.2022AI21 Labsai21.com$3.78BIsrael
18.03.2022Heirloomheirloomcarbon.com$203MUnited Sta...
03.03.2022Phaidraphaidra.ai$87MUnited Sta...
Show more

News 32

DateTitleDescription
24.11.2021Animal-free Cheese Brand, New Culture, Closes Their $25m Series A Investment-
04.05.2021ZOE Announces $53M Total Raise From Investors Including Fund Backed By Top Scientists, and Two-Time Super Bowl Champion Eli Manning-
22.04.2021Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging-
25.02.2021Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target-
03.02.2021Applications Open: AI/ML Deal Flow Internship-
03.02.2021Applications Open: Global Venture Intern-
14.01.2021Applications Open for Summer 2021: Life Sciences Summer Associate-
14.01.2021Applications Open for Summer 2021: Technology Summer Associate-
18.12.2020GSK and Ahren Announce Co-Led Series A Investment in Adrestia, and Multi-Project Discovery Collaboration with Each of the Five Projects Eligible To Receive Up To $230M (£172M) in Post Option Milestone...-
19.11.2020Zapata Computing Announces $38 Million Funding for Series B Financing to Accelerate the Commercial Adoption of Quantum Computing Technologies and Applications-
Show more

Mentions in press and media 28

DateTitleDescription
14.01.2026OutSee Secures £2.5M, Propels AI Genomics for Drug DiscoveryOutSee secured a significant £2.5M seed funding round. Ahren Innovation Capital spearheaded the investment. This capital fuels OutSee's groundbreaking AI-powered Nomaly platform. Nomaly uses a "genomics-first" approach. It predict...
12.01.2026OutSee: £2.5 Million Seed Round Completed And Partnership With o2h DiscoveryOutSee, an AI-enabled genomics and drug discovery company, has closed a £2.5 million seed funding round and signed a strategic agreement with o2h discovery to begin a collaborative drug discovery programme around OutSee’s lead drug target c...
10.12.2025Nu Quantum Raises $60M Series A in Largest Financing Round for Quantum Computer NetworkingNew investors, including National Grid Partners, Gresham House Ventures and Morpheus Ventures, validate growing demand for modular, scaling networking technologies within quantum computing. The oversubscribed funding round will accelerate N...
17.09.2025Hiverge Raises $5M in Seed FundingHiverge, a Cambridge, UK-based company enabling businesses access to algorithms that continually adapt to changing environments, raised $5M in Seed funding. The round was led by Flying Fish Ventures with Ahren Innovation Capital and Jeff De...
24.07.2025Bitfount Secures $8M to Revolutionize Clinical Research with Federated AIBitfount secured $8 million in Series A funding. This capital fuels its privacy-preserving federated AI platform. It revolutionizes clinical research collaboration. The technology eliminates raw data sharing. It brings algorithms directly t...
24.07.2025Bitfount raises $8m in Series A funding roundLONDON, UK, July 23, 2025 – Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Ad...
23.07.2025London’s Bitfount raises €6.8 million to break down clinical research data silos with federated AI networkHealthTech platform Bitfount, a British federated AI platform innovating clinical research collaboration, has secured €6.8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Advi...
23.07.2025Bitfount raises $8M to unlock clinical research data with federated AILondon-based Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Bitfount removes the data-...
25.06.2025OutSee Secures £1.8M Seed Funding to Revolutionize Drug DiscoveryIn the world of genomics and drug discovery, innovation is the lifeblood. OutSee, a Cambridge-based company, has just injected new energy into this field by securing £1.8 million in seed funding. This financial boost, led by Ahren Innovatio...
24.06.2025OutSee raises £1.8M to expand therapeutic pipeline using predictive genomicsCambridge-based OutSee has secured £1.8 million in seed funding. The company has previously received over £500,000 in precision medicine grants from Innovate UK to support technology extensions and to test their application on dementia case...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In